痰热清注射液对老年重症肺炎并发脓毒症患者HMGB1水平的影响

张慈; 崔紫阳; 王昊辰; 张盼盼; 陈前程; 李立群; 王红阳

doi:10.13201/j.issn.1009-5918.2019.01.010

痰热清注射液对老年重症肺炎并发脓毒症患者HMGB1水平的影响

- 华北理工大学附属医院呼吸内科(河北唐山, 063000)
基金项目:
河北省卫生与计划生育委员会科技研究计划课题 (No:20170903)

详细信息

通讯作者: 王红阳,E-mail:tsmywhy@163.com

中图分类号: R631

收稿日期: 2018-11-12

Effect of Tanreqing injection on HMGB1 levels in elderly patients with severe pneumonia complicated with sepsis

- Department of Respiratory Medicine, North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, 063000, China

More Information

Corresponding author: WANG Hongyang, E-mail: tsmywhy@163.com

Received Date: 12 November 2018

摘要

摘要: 目的:探讨痰热清注射液对老年重症肺炎相关性脓毒症患者高迁移率蛋白B1水平的影响。方法:选择2017-01-2018-03期间就诊于我院的78例老年重症肺炎并发脓毒症患者, 依据随机数字表法分为治疗组和对照组, 两组均给予脓毒症集束化治疗, 治疗组加用痰热清注射液20ml静脉滴注, 1次/d, 连续使用7d。观察两组患者治疗前后血清HMGB1、PCT、急性生理和慢性健康状况评估 (APACHE) Ⅱ评分变化。结果:两组患者入科后的血清HMGB1、PCT及APACHEⅡ评分比较差异均无统计学意义 (均P＞0.05);治疗组治疗前血清HMGB1、PCT及APACHEⅡ评分显著高于治疗后 (P＜0.05);治疗后对照组血清HMGB1、PCT及APACHEⅡ评分高于治疗组 (均P＜0.05);治疗组治疗前, 患者血清HMGB1水平与PCT水平呈正相关 (r=0.979, P＜0.05);HMGB1与APACHEⅡ评分呈正相关 (r=0.973, P＜0.05);PCT水平与APACHEⅡ评分呈正相关 (r=0.978, P＜0.05);治疗组治疗后, 患者血清HMGB1水平与PCT水平呈正相关 (r=0.972, P＜0.05);HMGB1与APACHEⅡ评分呈正相关 (r=0.981, P＜0.05);PCT水平与APACHEⅡ评分呈正相关 (r=0.973, P ＜0.05)。结论:痰热清可改善老年重症肺炎并发脓毒症患者病情, 降低血清HMGB1、PCT水平及APACHEⅡ评分, 从而改善预后。
- 脓毒症 /
- 重症肺炎 /
- 老年 /
- 痰热清注射液 /
- 高迁移率蛋白B1
Abstract: Objective: To investigate the effect of Tanreqing injection on the levels of high mobility protein B1 in elderly patients with severe pneumonia-related sepsis.Method: Seventy-eight elderly patients with severe pneumonia complicated with sepsis who were treated in our hospital from January 2017 to March 2018 were selected and divided into treatment group and control group according to random number table method.Both groups were treated with sepsis cluster therapy.The treatment group was treated with 20 ml Tanreqing injection intravenously once a day for 7 consecutive days.The changes of serum HMGB1, PCT, APACHEⅡ scores were observed before and after treatment.Result: There was no significant difference in serum HMGB1, PCT and APACHEⅡ scores between the two groups at admission (all P＞0.05);the scores of serum HMGB1, PCT and APACHEⅡ before treatment in the treatment group were significantly higher than those after treatment (P＜0.05);the scores of serum HMGB1, PCT and APACHEⅡin the control group were higher than those in the treatment group after treatment (all P＜0.05).Before treatment, serum HMGB1 level of treatment group was positively correlated with PCT level (r=0.979, P＜0.05);HMGB1 was positively correlated with APACHEⅡscore (r=0.973, P＜0.05);PCT level was positively correlated with APACHEⅡ score (r=0.978, P＜0.05);after treatment, serum HMGB1 level of treatment group was positively correlated with PCT level (r=0.972, P＜0.05);HMGB1 was positively correlated with APACHEⅡ score (r=0.981, P＜0.05);PCT level was positively correlated with APACHEⅡ score (r=0.973, P＜0.05).Conclusion: Tanreqing reduced the levels of serum HMGB1, PCT and APACHEⅡ score of elderly patients with severe pneumonia complicated with sepsis, thereby improved the prognosis.
- sepsis /
- severe pneumonia /
- geriatric /
- Tanreqing injection /
- high mobility group protein B1

HTML全文

参考文献(19)

[1]	Han J, Zhong J, Wei W, et al.Extracellular high-mobility group box 1acts as an innate immune mediator to enhance autoimmune progression and diabetes onset in NOD mice[J].Diabetes, 2008, 57 (8):2118-2127.
[2]	张志华, 郑光, 郭洪涛, 等.痰热清注射液临床应用文献分析[J].中成药杂志, 2014, 36 (1):52-55.
[3]	Mandell LA, Wunderink RG, Anzueto A, et al.Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults[J].Clin Infect Dis, 2007, 44 (Suppl 2):S27-S72.
[4]	薄禄龙, 卞金俊, 邓小明.2016年脓毒症最新定义与诊断标准:回归本质重新出发[J].中华麻醉学杂志, 2016, 36 (3):259-262.
[5]	于学忠, 姚永明, 周荣斌.中国脓毒症/脓毒症休克急诊治疗指南 (2018)[J].临床急诊杂志, 2018, 19 (9):423-444.
[6]	王海峰, 李建生, 余学庆, 等.基于文献的重症肺炎中医证素组合规律研究[J].辽宁中医杂志, 2009, 36 (12):2059-2061.
[7]	Wong YH, Lee TY, Liang HK, et al.Kinase Phos 2.0:a web server for identifying protein kinase-specific phosphorylation sites based on sequences and coupling patterns[J].Nucleic Acids Res, 2007, 35 (Web server issue):W588-W594.
[8]	Voncken JW, Niessen H, Neufeld B, et al.MAPKAP kinase 3pK phosphorylates and regulates chomatin association of the polycomb group protein Bmil[J].J Biol Chem, 2005, 280 (7):5178-5187.
[9]	Wang H, Bloom O, Zhang M, et al.HMG-1as a late mediator of endotoxin lethality in mice[J].Science, 1999, 285 (5425):248-251.
[10]	田小星, 吴传新, 孙航, 等.丙酮酸乙酯抑制LPS诱导RAW264.7巨噬细胞HMGB1的表达[J].细胞与分析免疫学杂志, 2011, 27 (12):1304-1307.
[11]	Anderson U, Wang H, Palmblad K, et al.High mobility group 1protein (HMG-1) stimulates proinflammatory cytoline synthesis in human monocytes[J].J Exp Med, 2000, 192 (4):565-570.
[12]	Lotze MT, Zeh HJ, Rubanelli A, et al.The grateful dead:damage-associsted molecular pattern molecules and reduction/oxidation regular immunity[J].Immunol Rev, 2007, 220:60-81.
[13]	Park JS, Gamboni-Robertson F, He Q, et al.High mobility group box 1protein interacts with muliple Toll-like receptors[J].Am J Physiol Cell Physiol, 2006, 290 (3):C917-C924.
[14]	Yanai H, Matsuda A, An J, et al.Conditional ablation of HMGB1in mice reveals its protective function against endotoxemia and bacterial infection[J].Proc Natl Acad Sci USA, 2013, 110 (51):20699-20704.
[15]	Karlsson S, Heikkinen M, Pettila V, et al.Predictive value of procalcitonin decrease in patients with severe sepsis:a prospective observational study[J].Crit Care, 2010, 14 (6):R205.
[16]	Mathew B, Roy DD, Kumar TV.The use of procalcitonin as a marker of sepsis in children[J].J Clin Diagn Res, 2013, 7 (2):305-307.
[17]	郭亚威, 王萌, 朱丹丹, 等.降钙素原联合脓毒症死亡风险评分对老年脓毒症患者预后的评估价值[J].临床急诊杂志, 2018, 19 (7):447-449.
[18]	潘丽萍, 慈光胜, 谌溪元, 等.严重脓毒症患者预后的危险因素分析[J].临床急诊杂志, 2016, 17 (10):767-771.
[19]	周静, 石振东.痰热清注射液治疗老年重症肺炎的临床疗效及对血清超敏C反应蛋白、降钙素原的影响[J].检验医学与临床, 2017, 14 (11):1637-1639.